<doc><docmeta id="113hr820ih">
    <bill congress="113" type="hr" number="820" version="ih"/>
    <revision id="7" commit-time="2013-03-25T22:03:05+00:00" comitter="/users/favila.xml" doc="/docs/113hr820ih/7.xml" status="complete"><description>Edited via AKN</description></revision>
</docmeta><bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H2E81C4E1C78E46118CDF8773BF04FAC6" public-private="public">
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 820</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130226">February 26, 2013</action-date>
			<action-desc>
        <sponsor name-id="W000215">Mr. Waxman</sponsor> (for
			 himself and <cosponsor name-id="S000480">Ms. Slaughter</cosponsor>) introduced
			 the following bill; which was referred to the
			 <committee-name committee-id="HIF00">Committee on Energy and
			 Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Federal Food, Drug, and Cosmetic Act to
		  enhance the reporting requirements pertaining to use of antimicrobial drugs in
		  food animals.</official-title>
	</form>
	<legis-body id="H4134A82E7F1F49DBA465695FA307400D" style="OLC">
		<section id="HEA8AAC2DC18F411E817A596F2A541960" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Delivering Antimicrobial Transparency
			 in Animals Act of 2013</short-title>
        </quote>.</text>
		</section>
    <section id="HF0F74EB9641D40CE83C2D2E2A2582004">
      <enum>2.</enum>
      <header>Findings</header>
      <text display-inline="no-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> finds the following:</text>
			<paragraph id="H9CE7BBBA34D847359E600AA187D5F4BC">
        <enum>(1)</enum>
        <text>Antimicrobials are
			 of critical importance to public health and to the American economy.</text>
			</paragraph>
      <paragraph id="H24886017DDA840EF82B3C627C81E5887">
        <enum>(2)</enum>
        <text>Use of
			 antimicrobials, whether in human medicine or in agriculture, contributes to the
			 development and spread of antimicrobial resistance.</text>
			</paragraph>
      <paragraph id="H20FD6070B41248B59572EF75B855B200">
        <enum>(3)</enum>
        <text>Data from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food
			 and Drug Administration</cato:entity-ref> (FDA) indicate that approximately 80 percent of all
			 antimicrobials sold in the United States, over 29,000,000 pounds in 2009, were
			 sold for use in food animals.</text>
			</paragraph>
      <paragraph id="H385063699F1947A3BDA158A69F24736B">
        <enum>(4)</enum>
        <text display-inline="yes-display-inline">A study published in September, 2012, in
			 Proceedings of the National Academy of Sciences of the United States of America
			 found that even low doses of antimicrobials in animal feed for short periods of
			 time increased the prevalence of the bacteria E. coli and the prevalence and
			 diversity of antimicrobial resistance genes in bacteria in pigs.</text>
			</paragraph>
      <paragraph id="HFA1FB98747AC4A5A8B22C612BB0B9B8E">
        <enum>(5)</enum>
        <text><cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation"><cato:entity-ref entity-type="public-law" value="public-law/110/316">Public Law
			 110–316</cato:entity-ref>, the <cato:entity-ref entity-type="act" value="Animal Drug User Fee Amendments of 2008">Animal Drug User Fee Amendments of 2008</cato:entity-ref></cato:entity>, requires producers of
			 drugs used in food animals to provide specified information annually to the FDA
			 on the sales and indications for use of such drugs.</text>
			</paragraph>
      <paragraph id="H03384DD677B944FAB490A6A56EAD8645">
        <enum>(6)</enum>
        <text>A
			 September 2011 study by the Government Accountability Office found that the
			 data provided to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">FDA</cato:entity-ref> under the Animal Drug User Fee Amendments Act of 2008
			 lacked sufficient details necessary to analyze trends in antimicrobial
			 resistance, such as information on actual drug use in specific food-producing
			 animal species.</text>
			</paragraph>
    </section>
    <section id="H2D836FD92ECE4013B8718834F4465F78">
      <enum>3.</enum>
      <header>Purpose</header>
      <text display-inline="no-display-inline">The purpose of this Act is to provide the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> and the public with better information on the use
			 of antimicrobial drugs in animals used for food to—</text>
			<paragraph id="H1D19EC54D6AA4EACB888E12BAD7089AC">
        <enum>(1)</enum>
        <text>enable public
			 health officials and scientists to better understand and interpret trends and
			 variations in rates of microbial resistance to such antimicrobial drugs;</text>
			</paragraph>
      <paragraph id="H5EE01645EC134EDC87B2D052019F583D">
        <enum>(2)</enum>
        <text display-inline="yes-display-inline">improve the understanding of the
			 relationship between antimicrobial drug use in animals used for food and
			 antimicrobial drug resistance in microbes in and on animals and humans;
			 and</text>
			</paragraph>
      <paragraph id="H42B7968080D3483AB1F419BC5B507C50">
        <enum>(3)</enum>
        <text display-inline="yes-display-inline">identify interventions to prevent and
			 control such antimicrobial drug resistance.</text>
			</paragraph>
    </section>
    <section id="HE83974020C0340E092A0A0713D6D423F">
      <enum>4.</enum>
      <header>Enhanced
			 reporting requirements</header>
			<subsection id="H53308200DB1F414797B12A2B6A69580C">
        <enum>(a)</enum>
        <header>Reports</header>
        <text><cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation"><cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l">Section
			 512(l) of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/360b/l">21 U.S.C. 360b(l)</cato:entity-ref>)</cato:entity> is
			 amended by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:3">paragraph (3)</cato:entity-ref> and inserting the following:</text>
				<quoted-block display-inline="no-display-inline" id="H8C5E6A50027D4D98A0CEF4A4F5971965" style="OLC">
					<paragraph id="H4884F13541DF4BCFBCC7F291605B8F8C">
            <enum>(3)</enum>
            <subparagraph commented="no" display-inline="yes-display-inline" id="HDC35B646D91646BA8846C1D03EE88D36">
              <enum>(A)</enum>
              <text>In the case of each new
				animal drug described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:1">paragraph (1)</cato:entity-ref> that contains an antimicrobial active
				ingredient, the sponsor of the drug shall submit an annual report to the
				Secretary on the amount of each antimicrobial active ingredient in the drug
				that is sold or distributed for use in food-producing animals, including
				information on any distributor-labeled product.</text>
						</subparagraph>
            <subparagraph id="HE7EAF9B628F44C5FAD5E469EE91AD005" indent="up1">
              <enum>(B)</enum>
              <text>Each report under this paragraph shall
				specify the amount of each antimicrobial active ingredient—</text>
							<clause id="HB0059FB04F634645BFB3DA9781A750E1">
                <enum>(i)</enum>
                <text>by container size, strength, and
				dosage form;</text>
							</clause>
              <clause id="H226D58CAA43F49F484775C90E88B21F5">
                <enum>(ii)</enum>
                <text>by quantities distributed to each
				State domestically and by quantities exported; and</text>
							</clause>
              <clause id="HABBC7FE5B84344E281D40CDA9958E385">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">by dosage form, including (for each dosage
				form) the known or estimated amounts of the antimicrobial active ingredient
				sold or distributed for use in each food-producing animal for which the new
				animal drug is approved, including a description of the methods used to
				determine or estimate the amounts.</text>
							</clause>
            </subparagraph>
          </paragraph>
          <paragraph id="H6807DA84742641A4805837FBEB8AF9CA">
            <enum>(4)</enum>
            <subparagraph commented="no" display-inline="yes-display-inline" id="HA04B0F8C5A5A4320B3C242EA86EA9761">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">Subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:4/sp:B" proposed="true">subparagraph (B)</cato:entity-ref>, in the case of
				animal feed in final formulation bearing or containing a new animal drug for
				which reporting is required under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:3" proposed="true">paragraph (3)</cato:entity-ref>, a live poultry dealer, swine
				contractor, or feed lot operator who purchases, contracts, or manufactures such
				feed shall submit to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> an annual report that specifies, by
				food-producing animal for which the new animal drug is approved and, where
				applicable as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, by production class of such
				animal—</text>
							<clause id="HCCA84742422D4AE0B8E95A3B46E01314" indent="up1">
                <enum>(i)</enum>
                <text>the amount of each antimicrobial
				active ingredient contained per kilogram of each such feed sold or distributed
				for that animal and, where applicable, production class;</text>
							</clause>
              <clause id="H695D7E74E898483985A5449CF6BC36DB" indent="up1">
                <enum>(ii)</enum>
                <text>the quantity of such feed sold or
				distributed for that animal and, where applicable, production class; and</text>
							</clause>
              <clause id="H36047F3CA09C4103A79EF46EAD157E21" indent="up1">
                <enum>(iii)</enum>
                <text>for each such feed sold or
				distributed under a veterinary feed directive—</text>
								<subclause id="HC0C85D5099244340AFD74936A21604DA">
                  <enum>(I)</enum>
                  <text>the indications for which the feed was
				sold or distributed and the quantities of such feed that were sold or
				distributed per each such indication;</text>
								</subclause>
                <subclause id="H78A3995D483940CAAD01E4077CB902A8">
                  <enum>(II)</enum>
                  <text>the number of individuals of the
				food-producing animal and, where applicable, the production class to which the
				feed was intended; and</text>
								</subclause>
                <subclause id="HD63A36D4349D4C3D9DAE68878BF66269">
                  <enum>(III)</enum>
                  <text>the length of time over which the feed
				was intended to be provided to the animals and the dose of the active
				antimicrobial ingredient the animals were intended to receive.</text>
								</subclause>
              </clause>
            </subparagraph>
            <subparagraph id="HC69BF3C05E9E42478C27D1E2BFCF77C1" indent="up1">
              <enum>(B)</enum>
              <clause commented="no" display-inline="yes-display-inline" id="H0C38C81047F6445EA9A83A5025848F9B">
                <enum>(i)</enum>
                <text><cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:4/sp:A" proposed="true">Subparagraph (A)</cato:entity-ref> does
				not apply to a live poultry dealer, swine contractor, or feed lot operator if
				the total value of the live animals owned, purchased, sold, contracted for, or
				otherwise controlled by the dealer, contractor, or operator, directly or
				through subsidiaries or affiliates, per year, does not exceed—</text>
								<subclause id="HDE193865FD35459BA2CF94DB297C9AB4" indent="up1">
                  <enum>(I)</enum>
                  <text>$10,000,000; or</text>
								</subclause>
                <subclause id="H8598EBF9139244E5B0FB65E3E8E20E82" indent="up1">
                  <enum>(II)</enum>
                  <text>such other sum as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				may specify through regulation.</text>
								</subclause>
              </clause>
              <clause commented="no" id="HE5FDFCDC4BE14D84AB2CE873793CD23B" indent="up1">
                <enum>(ii)</enum>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may specify through
				regulation alternative reporting requirements, including via pilot programs or
				based on the results of pilot programs—</text>
								<subclause id="H16ABFA7068DC4FA9ACC758D791333398">
                  <enum>(I)</enum>
                  <text>to improve the accuracy of
				reports;</text>
								</subclause>
                <subclause id="HDDB5A221E08943E0BF69FB8E60722BBD">
                  <enum>(II)</enum>
                  <text>to lessen the burden of
				reporting;</text>
								</subclause>
                <subclause id="H115561E068AB4192B2FA9DFB557B2C73">
                  <enum>(III)</enum>
                  <text>to facilitate the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary’s</cato:entity-ref>
				ability to provide public summaries of the reports; or</text>
								</subclause>
                <subclause id="H4A8999B023D041319803D29ED08C4A33">
                  <enum>(IV)</enum>
                  <text>to improve the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary’s</cato:entity-ref> ability
				to use the reports, or the public’s ability to use the summaries under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:5" proposed="true">paragraph (5)</cato:entity-ref>, to understand the relationship between sales, distribution, and
				end-use practices with respect to feed containing new animal drugs described in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:1">paragraph (1)</cato:entity-ref> and antimicrobial resistance trends in microbes in animals,
				animal food products, and humans.</text>
								</subclause>
              </clause>
            </subparagraph>
          </paragraph>
          <paragraph id="H82632D8D471C4BEABA141B04FD88343D">
            <enum>(5)</enum>
            <subparagraph commented="no" display-inline="yes-display-inline" id="H065CB293E3424D45916574B57361FC0D">
              <enum>(A)</enum>
              <text>Each report under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:3" proposed="true">paragraph (3)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:4" proposed="true">(4)</cato:entity-ref> shall—</text>
							<clause id="H312918436CEC47D89BD9C6847F988FF7" indent="up1">
                <enum>(i)</enum>
                <text>be submitted electronically not
				later than March 31 each year;</text>
							</clause>
              <clause id="H62663E23E05B4D9E8E8FEC38FFD11DCA" indent="up1">
                <enum>(ii)</enum>
                <text>cover the period of the preceding
				calendar year;</text>
							</clause>
              <clause id="HA896BB9FE5874C78B1856E70AE666AE5" indent="up1">
                <enum>(iii)</enum>
                <text>include separate information for
				each month of such calendar year; and</text>
							</clause>
              <clause id="HC88F2473D6B94DB9B1613AD999C63BDE" indent="up1">
                <enum>(iv)</enum>
                <text>be in such format as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				may require.</text>
							</clause>
            </subparagraph>
            <subparagraph id="H014ADB41165E41388FDEC73A30EBF7DF" indent="up1">
              <enum>(B)</enum>
              <text>In specifying a format under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:5/sp:A/cl:iv" proposed="true">subparagraph (A)(iv)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall seek to ensure that such format
				enables the data reported to be integrated or otherwise easily associated and
				compared with data from other Federal databases containing data on—</text>
							<clause id="H96A34BE8D8974CF3A32585E553032F9B">
                <enum>(i)</enum>
                <text>drug sales for human use;
				and</text>
							</clause>
              <clause id="H5BA754BAEEB74D089A342505931F665B">
                <enum>(ii)</enum>
                <text>rates of antimicrobial resistance
				in bacteria in and on animals, animal food products, and people.</text>
							</clause>
            </subparagraph>
            <subparagraph id="H81B86DBBF46C405B9AC2227612F0C898" indent="up1">
              <enum>(C)</enum>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may share information
				reported under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:3" proposed="true">paragraph (3)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:4" proposed="true">(4)</cato:entity-ref> with the Antimicrobial Resistance Task
				Force established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E">section 319E of the Public Health Service Act</cato:entity-ref>.</text>
						</subparagraph>
            <subparagraph id="H61CD38348B6747D48CA312F9553FA1D9" indent="up1">
              <enum>(D)</enum>
              <clause commented="no" display-inline="yes-display-inline" id="H8EB3AFAA2C60415F943997717C4BDC8F">
                <enum>(i)</enum>
                <text>Not later than November
				30 each year, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall make publicly available summaries of the
				information reported under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:3" proposed="true">paragraphs (3)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:4" proposed="true">(4)</cato:entity-ref>.</text>
							</clause>
              <clause id="H0F4203BEA45C43ED849D34FC7BFA2555" indent="up1">
                <enum>(ii)</enum>
                <text>For each summary under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:5/sp:D/cl:i" proposed="true">clause (i)</cato:entity-ref>,
				except as provided in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:5/sp:D/cl:iii" proposed="true">clause (iii)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall—</text>
								<subclause id="HB0FB7C37AA334640B840CBE0C9BE5F85">
                  <enum>(I)</enum>
                  <text>report data by antimicrobial drug
				class;</text>
								</subclause>
                <subclause id="HF83716374C5F47B1A732E4DED4173922">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">for each such antimicrobial drug class,
				specify—</text>
									<item id="H3E40CDDDA7274B30939F808BDBF086DD">
                    <enum>(aa)</enum>
                    <text>the quantity of drugs sold or
				distributed per dosage form;</text>
									</item>
                  <item id="H921767A6367A4E8AAB6E2D8DBD1DB73C">
                    <enum>(bb)</enum>
                    <text>the percentage of drugs sold or
				distributed with labeled indications that fall within each of the following
				categories: growth promotion, feed efficiency, or other production purposes;
				disease prevention; disease control; and disease treatment;</text>
									</item>
                  <item id="HA12219833AA24CAA85443297B1613068">
                    <enum>(cc)</enum>
                    <text>the quantity of drugs sold or
				distributed per each of the following marketing categories: over-the-counter,
				prescription, and veterinary feed directive;</text>
									</item>
                  <item id="H24FE5D7A73594CCBA49CEE0CA71472E2">
                    <enum>(dd)</enum>
                    <text>the quantity of drugs sold or
				distributed per State of sale or distribution; and</text>
									</item>
                  <item id="H2790FEA963C14B5CB728B07D44285587">
                    <enum>(ee)</enum>
                    <text display-inline="yes-display-inline">the
				known or estimated quantity of drugs sold or distributed for each
				food-producing animal and, where feasible, production class of such animal;
				and</text>
									</item>
                </subclause>
                <subclause id="H6CA56796209A47AB923EB17DEA40AE24">
                  <enum>(III)</enum>
                  <text>for each feed sold or
				distributed under a veterinary food directive for which reporting is required
				under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:4" proposed="true">paragraph (4)</cato:entity-ref>, include the information reported pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:4/sp:A/cl:iii/scl:I,II" proposed="true">subclauses
				(I), (II), and (III) of paragraph (4)(A)(iii)</cato:entity-ref>.</text>
								</subclause>
              </clause>
              <clause id="HACD96B279A064D52B7C9749C31DA68A1" indent="up1">
                <enum>(iii)</enum>
                <text>For any antimicrobial drug class
				with fewer than 3 sponsors of approved new animal drugs, instead of reporting
				data under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:5/sp:D/cl:ii" proposed="true">clause (ii)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall for each such class—</text>
								<subclause id="HDCFA20EDFE554EE79DD6F2D2C0781044">
                  <enum>(I)</enum>
                  <text>report data by category of
				importance of the antimicrobial drugs within that class to human medicine, as
				determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>; and</text>
								</subclause>
                <subclause id="H8314D75294EC4477A11107ABE2D1791E">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">to the extent feasible for each such
				category, specify—</text>
									<item id="H3F953104288047A29565593DD2BB149A">
                    <enum>(aa)</enum>
                    <text>the quantity of drugs sold or
				distributed per dosage form;</text>
									</item>
                  <item id="H182886EDE4E74E568DA6EC87D3003484">
                    <enum>(bb)</enum>
                    <text>the percentage of drugs sold or
				distributed with labeled indications that fall within each of the following
				categories: growth promotion, feed efficiency, or other production purposes;
				disease prevention; disease control; and disease treatment;</text>
									</item>
                  <item id="H66F7E20F5CC645AFA52C31495FB2A754">
                    <enum>(cc)</enum>
                    <text>the quantity of drugs sold or
				distributed per each of the following marketing categories: over-the-counter,
				prescription, and veterinary feed directive; and</text>
									</item>
                  <item id="H114F719C907D4426B8890F8D87A728C3">
                    <enum>(dd)</enum>
                    <text>the quantity of drugs sold or
				distributed per State of sale or distribution.</text>
									</item>
                </subclause>
              </clause>
              <clause id="H1B3BED3407804371A601289AE3D4243F" indent="up1">
                <enum>(iv)</enum>
                <text>In carrying out this subparagraph,
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall report data in a manner consistent with protecting both
				national security and confidential business information.</text>
							</clause>
            </subparagraph>
            <subparagraph id="H4097BD2B885C4DAE80EB82FF9B05FBB4" indent="up1">
              <enum>(E)</enum>
              <text>In this paragraph, the terms
				<term>live poultry dealer</term> and <term>swine contractor</term> have the
				meanings given to those terms in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Packers and Stockyards Act, 1921/s:2">section 2 of the Packers and Stockyards Act,
				1921</cato:entity-ref>.</text>
						</subparagraph>
          </paragraph>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
      <subsection id="H6BFCB147F1E94069B27FF83804494D4C">
        <enum>(b)</enum>
        <header>Rule of
			 application</header>
        <text display-inline="yes-display-inline">The amendment
			 made by this section applies to reports under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation"><cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:3" proposed="true">paragraphs (3)</cato:entity-ref> and <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:4" proposed="true">(4) of section
			 512(l) of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/360b/l">21 U.S.C. 360b(l)</cato:entity-ref>)</cato:entity> (as
			 amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Delivering Antimicrobial Transparency in Animals Act of 2013/s:4/ss:a" proposed="true">subsection (a)</cato:entity-ref>) that cover the period of calendar year 2014 or any
			 subsequent calendar year. The provisions of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512/ss:l/p:3" proposed="true">section 512(l)(3) of such Act</cato:entity-ref>, as
			 in effect the day before the date of enactment of this Act, apply to reports
			 that cover the period of calendar year 2013.</text>
			</subsection>
    </section>
    <section id="H0F690BA3C3394123ABB997A4971AD3DF">
      <enum>5.</enum>
      <header>Enhanced
			 collaboration between the Food and Drug Administration and the Department of
			 Agriculture</header>
      <text display-inline="no-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of
			 Health and Human Services</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner of Food and Drugs</cato:entity-ref>,
			 shall increase collaboration and coordination with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1200">Secretary of Agriculture</cato:entity-ref>
			 to expand and coordinate the collection of data on the use of antimicrobial
			 drugs in or on cattle, swine, chickens, turkeys, and such other food-producing
			 animal species as agreed to by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref> and
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1200">Secretary of Agriculture</cato:entity-ref>, including by providing information to the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1200">Secretary of Agriculture</cato:entity-ref> for use by—</text>
			<paragraph id="H3E38074FA935482AA97CB0296BC38588">
        <enum>(1)</enum>
        <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="12K3">Animal and
			 Plant Health Inspection Service</cato:entity-ref> to help inform its collection of data through
			 the National Animal Health Monitoring System; and</text>
			</paragraph>
      <paragraph id="HF6F33E474F794398A0DFB4F26F56C64C">
        <enum>(2)</enum>
        <text display-inline="yes-display-inline">the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="12H4">Economic Research Service</cato:entity-ref> to help
			 inform its collection of data through the Agricultural Resource Management
			 Survey.</text>
			</paragraph>
    </section>
    <section id="HC69ACAE50AC342C8B9138576B302E007">
      <enum>6.</enum>
      <header>Action by
			 Government Accountability Office</header>
			<subsection id="H9FDD220183AB4140835964C726FEF073">
        <enum>(a)</enum>
        <header>Publication of
			 final guidance</header>
        <text>Not later than 180 days after the date of
			 enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref> shall publish
			 a final version of draft guidance #213, entitled <quote>New Animal Drugs and
			 New Animal Drug Combination Products Administered in or on Medicated Feed or
			 Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for
			 Voluntarily Aligning Product Use Conditions with GFI #209</quote>.</text>
			</subsection>
      <subsection id="HC2D8134C542F49D2BF292A19D42D7868">
        <enum>(b)</enum>
        <header>Report by
			 GAO</header>
				<paragraph id="H74299C166C384152B6D67B8E6333016C">
          <enum>(1)</enum>
          <header>In
			 general</header>
          <text>Not later than 3 years after the publication of final
			 guidance pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Delivering Antimicrobial Transparency in Animals Act of 2013/s:6/ss:a" proposed="true">subsection (a)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0500">Comptroller General</cato:entity-ref> of the United
			 States shall commence a study to evaluate—</text>
					<subparagraph id="H9261C398630F4FC2B998C72E3BD0101D">
            <enum>(A)</enum>
            <text>the voluntary
			 approach used by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> to eliminate injudicious use
			 of antimicrobial drugs in food-producing animals; and</text>
					</subparagraph>
          <subparagraph id="H91FDC8C336A94B4E9665890885FEFE0C">
            <enum>(B)</enum>
            <text>the effectiveness
			 of the data collection activities conducted by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>
			 regarding antimicrobial resistance.</text>
					</subparagraph>
        </paragraph>
        <paragraph id="H5AD7B1C82B9E401D848986B78C6C141C">
          <enum>(2)</enum>
          <header>Report</header>
          <text>Not
			 later than 1 year after commencing the study required by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Delivering Antimicrobial Transparency in Animals Act of 2013/s:6/ss:b/p:1" proposed="true">paragraph (1)</cato:entity-ref>, the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0500">Comptroller General</cato:entity-ref> of the United States shall submit to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="SSHR00">Committee on
			 Health, Education, Labor, and Pensions of the Senate</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="HIF00">Committee on
			 Energy and Commerce of the House of Representatives</cato:entity-ref> a report that describes the
			 results of such study.</text>
				</paragraph>
      </subsection>
    </section>
  </legis-body>
</bill></doc>